Past, present and future of hepatitis E virus infection: Zoonotic perspectives

The origin of hepatitis E virus (HEV) is not fully understood, but it is considered an emerging zoonotic pathogen. To date, HEV has been isolated from many animal species. The family Hepeviridae consists of two genera. The genus Orthohepevirus includes four distinct species (A, B, C, and D), each with distinct genotypes. Within the Orthohepevirus A species, HEV-1 and HEV-2 host ranges are restricted to humans, whereas genotypes 3 and 4 primarily infect a wide range of diverse animal species, in addition to being zoonotic to humans. Swine and wild boar species were previously thought to be the primary natural HEV reservoir, but recently rabbits have also been identified as major carriers. Moreover, increasing the number of HEV infections within the food supply chain underscore the important role of farming and food processing practices in limiting virus transmission. Notably, a Chinese commercial vaccine has the potential to protect humans and possibly animal reservoirs from HEV infection. This review summarizes the status of HEV infection worldwide in different animal species and outlines various modes of zoonotic transmission, with reference to cross-species transmission and recent vaccine developments. •Hepatitis E is an infectious inflammation of the liver caused by hepatitis E virus (HEV).•Domestic swine and wild boar are major reservoirs of HEV infection.•The main routes of transmission are water borne, food borne and zoonotic routes.•The recombinant HEV commercial vaccine is available but there is no effective vaccine for zoonotic HEV infection in humans.•Chinese vaccines have the potential to protect humans and possibly animal reservoirs from HEV infection.